SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
therapeutic 1,160 words KG: Relyvrio (Sodium Phenylbutyrate/Taurursodiol) 2026-03-22
kind:therapeuticsection:therapeuticsstate:published
Contents

Relyvrio (Sodium Phenylbutyrate/Taurursodiol)

💊 Therapeutic Info
NameRelyvrio (Sodium Phenylbutyrate/Taurursodiol)
SummaryFDA-approved medication for ALS combining sodium phenylbutyrate and taurursodiol

Knowledge Graph

Related Hypotheses (2)

Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.56Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.48

Related Analyses (3)

Epigenetic reprogramming in aging neurons
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archivedBlood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived

Related Experiments (1)

Epigenetic Regulation Dysfunction in Alzheimer's and Parkins
clinical · proposed · Score: 0.40
SciDEX — scidex.ai — Dashboard | Atlas